A comparison of microbial growth in alfaxalone, propofol and thiopental: Paper

Journal of Small Animal Practice

Volumn 49, Issue 4, 2008, Pages 186-190

  Strachan, F A ^a   Mansel, J C ^a   Clutton, R E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFAXALONE; ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; PREGNANEDIONE; PROPOFOL; THIOPENTAL;

ARTICLE; BACTERIAL COUNT; COMPARATIVE STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; KINETICS; LABORATORY DIAGNOSIS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ANESTHETICS; ANESTHETICS, INTRAVENOUS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ESCHERICHIA COLI; KINETICS; MICROBIAL SENSITIVITY TESTS; PREGNANEDIONES; PROPOFOL; SPECIMEN HANDLING; STAPHYLOCOCCUS AUREUS; THIOPENTAL; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 40749133767     PISSN: 00224510     EISSN: 17485827     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2007.00473.x     Document Type: Article

References (21)

1. Arduino, M. J., Bland, L. A., McAllister, S. K., Aguero, S. M., Villarino, M. E., McNeil, M. M., Jarvis, W. R. Favero, M. S. (1991) Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infection Control and Hospital Epidemiology 12, 535 539
2. Bennett, S. N., McNeil, M. M., Bland, L. A., Arduino, M. J., Villarino, M. E., Perrotta, D. M., Burwen, D. R., Welbel, S. F., Pegues, D. A., Stroud, L., Zeitz, P. S. Jarvis, W. R. (1995) Postoperative infections traced to contamination of an intravenous anesthetic, propofol. New England Journal of Medicine 333, 147 154
3. Crowther, J., Hrazdil, J., Jolly, D. T., Galbraith, J. C., Greacen, M. Grace, M 1996) Growth of microorganisms in propofol, thiopental and a 1:1 mixture of propofol and thiopental. Anesthesia and Analgesia 82, 475 478
4. Diprivan™ 10 mg/mL (1%) and 20 mg/mL (2%) Emulsion for Injection or Infusion Core Data Sheet 2006). London, UK : AstraZeneca
5. Haws, J. L., Herman, N., Clark, Y., Bjoraker, R. Jones, D 1998) The chemical stability and sterility of sodium thiopental after preparation. Anesthesia and Analgesia 86, 208 213
6. Heldmann, E., Brown, D. C. Shofer, F 1999) The association of propofol usage with postoperative wound infection rate in clean wounds: a retrospective study. Veterinary Surgery 28, 256 259
7. Henry, B., Plante-Jenkins, C. Ostrowska, K 2001) An outbreak of Serratia marcescens associated with the anesthetic agent propofol. American Journal of Infection Control 29, 312 315
8. Highsmith, A. K., Greenhood, G. P. Alien, J. R. (1982) Growth of nosocomial pathogens in multiple-dose parenteral medication vials. Journal of Clinical Microbiology 15, 1024 1028
9. Jarvis, W. R. Highsmith, A. K. (1984) Bacterial growth and endotoxin production in lipid emulsion. Journal of Clinical Microbiology 19, 17 20
10. Kuehnert, M. J., Webb, R. M., Jochimsen, E. M., Hancock, G. A., Arduino, M. J., Hand, S., Currier, M. Jarvis, W. R. (1997) Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol. Anesthesia and Analgesia 85, 420 425
11. Lorenz, I. H., Kolbitsch, C., Lass-Florl, C., Gritznig, I., Vollert, B., Lingnau, W., Moser, P. L. Benzer, A 2002) Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer's recommendations. Canadian Journal of Anesthesia 49, 347 352
12. Mchugh, G. J. Roper, G. M. (1995) Propofol emulsion and bacterial contamination. Canadian Journal of Anesthesia 42, 801 804
13. Quinn, P. J., Carter, M. E., Markey, B. Carter, G. R. (1994) Clinical Veterinary Microbiology. London, UK : Mosby International Ltd
14. Sakuragi, T., Yanagisawa, K., Shirai, Y. Dan, K 1999) Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine. Acta Anaesthesiologica Scandinavica 43, 476 479
15. Sosis, M. B. Braverman, B 1993) Growth of Staphylococcus aureus in four intravenous anesthetics. Anesthesia and Analgesia 77, 766 768
16. Sosis, M. B., Braverman, B. Villaflor, E 1995) Propofol, but not thiopental, supports the growth of Candida albicans. Anesthesia and Analgesia 81, 132 134
17. Trépanier, C. A. Lessard, M. R. (2003) Propofol and the risk of transmission of infection. Canadian Journal of Anesthesia 50, 533 537
18. Veber, B., Gachot, B., Bedos, J. P. Wolff, M 1994) Severe sepsis after intravenous injection of contaminated propofol. Anesthesiology 80, 712 713
19. Wachowski, I., Jolly, D. T., Hrazdil, J., Galbraith, J. C., Greacen, M. Clanachan, A. S. (1998) The growth of microorganisms in propofol and mixtures of propofol and lidocaine. Anesthesia and Analgesia 88, 209 212
20. Wong, C. L., Warriner, C. B., McCormack, J. P. Clarke, A. M. (1992) Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks. Canadian Journal of Anesthesia 39, 504 508
21. Young, J., Collete, T. S. Brehm, W. F. (1958) Sterility of multiple-dose vials after repeated use. American Surgeon 24, 811 814